Beijing Luzhu Biotechnology Co (HKSE:02480) Total Assets: HK$1,148.46 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02480 Beijing Luzhu Biotechnology Co Ltd HKSE:02480
24 GF Score
Price HK$13.00
! 3 Warning Signs
View Full Analysis

What is Beijing Luzhu Biotechnology Co Total Assets?

Beijing Luzhu Biotechnology Co HKSE:02480 24 Total Assets is HK$1,148.46 Mil as of Dec. 2025. GuruFocus rates HKSE:02480 with a GF Score™ of 24/100. The stock has 3 warning signs investors should review.

Beijing Luzhu Biotechnology Co's Total Assets for the quarter that ended in Dec. 2025 was HK$1,148.46 Mil.

During the past 12 months, Beijing Luzhu Biotechnology Co's average Total Assets Growth Rate was 7.50% per year. During the past 3 years, the average Total Assets Growth Rate was 7.90% per year.

During the past 5 years, Beijing Luzhu Biotechnology Co's highest 3-Year average Total Assets Growth Rate was 47.70%. The lowest was 7.90%. And the median was 27.80%.

Total Assets is connected with ROA %. Beijing Luzhu Biotechnology Co's annualized ROA % for the quarter that ended in Dec. 2025 was -13.84%. Total Assets is also linked to Revenue through Asset Turnover. Beijing Luzhu Biotechnology Co's Asset Turnover for the quarter that ended in Dec. 2025 was 0.00.

Beijing Luzhu Biotechnology Co  (HKSE:02480) Total Assets Explanation

Total Assets is connected with ROA %.

Beijing Luzhu Biotechnology Co's annualized ROA % for the quarter that ended in Dec. 2025 is

ROA %=Net Income (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=-160.814/( (1175.12+1148.463)/ 2 )
=-160.814/1161.7915
=-13.84 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Beijing Luzhu Biotechnology Co's Asset Turnover for the quarter that ended in Dec. 2025 is

Asset Turnover
=Revenue (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=0/( (1175.12+1148.463)/ 2 )
=0/1161.7915
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Beijing Luzhu Biotechnology Co Total Assets Related Terms

Beijing Luzhu Biotechnology Co Total Assets Historical Data

* Premium members only.

The historical data trend for Beijing Luzhu Biotechnology Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beijing Luzhu Biotechnology Co Total Assets Chart

Beijing Luzhu Biotechnology Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Total Assets
888.84 1,195.08 1,276.11 1,121.55 1,148.46

Beijing Luzhu Biotechnology Co Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Assets Get a 7-Day Free Trial Premium Member Only 1,276.11 1,186.60 1,121.55 1,175.12 1,148.46
HKSE:02480
24GF Score
Beijing Luzhu Biotechnology Co Ltd HKSE:02480
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beijing Luzhu Biotechnology Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Beijing Luzhu Biotechnology Co's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=729.25+419.213
=1,148.46

Beijing Luzhu Biotechnology Co's Total Assets for the quarter that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (Q: Dec. 2025 )+Total Liabilities (Q: Dec. 2025 )
=729.25+419.213
=1,148.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of HK$1,148.46 Mil mean?
Beijing Luzhu Biotechnology Co (HKSE:02480) has a Total Assets of HK$1,148.46 Mil as of Dec. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on Beijing Luzhu Biotechnology Co and its competitors.
Is Beijing Luzhu Biotechnology Co's Total Assets too high?
Beijing Luzhu Biotechnology Co's current Total Assets is HK$1,148.46 Mil. Overall, Beijing Luzhu Biotechnology Co has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Beijing Luzhu Biotechnology Co's Total Assets compare to VRTX and REGN?
Beijing Luzhu Biotechnology Co's Total Assets of HK$1,148.46 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Beijing Luzhu Biotechnology Co and its competitors. Beijing Luzhu Biotechnology Co's current Total Assets is HK$1,148.46 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Luzhu Biotechnology Co stock overvalued right now?
Beijing Luzhu Biotechnology Co (HKSE:02480) has a current Total Assets of HK$1,148.46 Mil. The current Total Assets is HK$1,148.46 Mil. Beijing Luzhu Biotechnology Co's overall GF Score™ is 24/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Beijing Luzhu Biotechnology Co (HKSE:02480), the current Total Assets is HK$1,148.46 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Beijing Luzhu Biotechnology Co Business Description

Address No. 3 Guangtong Street, Industrial Development Zone, Zhangjiawan Tongzhou District, Beijing, CHN
Beijing Luzhu Biotechnology Co., Ltd. is a biotechnology company committed to developing human vaccines and therapeutic biologics to prevent and control infectious diseases and treat cancer and autoimmune diseases. The Group's product pipeline consisted of three clinical-stage product candidates, including its Core Product, LZ901, and six pre-clinical-stage product candidates.
24GF Score

Get the complete analysis for HKSE:02480

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$13.00
Price